Table 3 Contents of the 4 predicted active components in the sample.

From: Exploring the mechanism of guben kechuan granules in the treatment of COPD via network pharmacology, molecular docking and molecular dynamics simulations

​Active Component

Average Content (µg/g)

RSD(%)

liquiritigenin

45.64

2.29

isoliquiritigenin

6.73

3.59

luteolin

0.25

7.09

psoralenol

98.55

11.93

Back to article page